Aussie court rules against Sanofi on Taxotere; Novo profits fall short;

 @FiercePharma: Who's the lead dog in Sanofi-Genzyme talks? Story | Follow @FiercePharma

> Sanofi-Aventis failed to block two generic drug manufacturers from selling a copy of the cancer drug Taxotere in Australia, as a federal court judge refused to bar the sale of the generics. Report

> Danish drugmaker Novo Nordisk reported a smaller-than-forecast rise in fourth-quarter profit, held back partly by increased costs, and raised 2011 profit guidance. News

> Cancer biomarker offers clues into when it will spread. Article

> Urine test may detect brain tumor biomarkers. Story 

> Danes begin biggest-ever resveratrol study. Report 

> Purdue Pharma launched an opioid-based continual-release analgesic for the treatment of chronic pain, in patch form. Article

> Biogen Idec reported that its fourth-quarter profit tumbled 21 percent, citing restructuring charges and rising expenses that outweighed the sales of key drugs. Report

> Glenmark Pharmaceuticals reported a 17 percent rise in consolidated quarterly net profit, largely in line with street estimates, on robust growth in domestic formulations business. Story

Biotech News

@FierceBiotech: Orexigen crashes after FDA demands pre-approval Contrave study. Item | Follow @FierceBiotech

@JohnCFierce: Just got off the phone with Pfizer worldwide R&D chief Mikael Dolsten. Pfizer is looking for central Cambridge facility to consolidate R&D. Follow @JohnCFierce

> Sanofi GLP-1 diabetes drug edges Byetta in Phase III study. Article 

> Reports: Sanofi and Genzyme agree on upper $70s, wrangle over cash vs CVR. News 

> Can Orexigen fund a major new cardio study of Contrave? Story

> Cambridge, MA a rare winner in Pfizer R&D gambit. News

Drug Delivery

> Plankton inspires stealth nano-armor for drug delivery. Story

> Gold nanoshells successfully zap glioma tumors. Report 

> Particle pretends it's iron to slip through blood-brain barrier. News

> C Dots approved for trials as imaging agent. Report 

Medical Devices

> Earnings: Covidien sees devices sales up 11%, Bard reports positive results. News 

> AnalizaDx looking for cancer-screening partner. Article 

> Teleflex switches CEOs. Story 

> J&J pays out $482M in patent infringement case. Report

> Kieran Gallahue to become new CareFusion CEO. Item 

> Volcano sees mixed decision in dispute with St. Jude unit. Story 

And Finally... Senate Republicans, seizing on a court ruling that the healthcare overhaul is unconstitutional, will push ahead with a vote to repeal the legislation; it's unlikely to succeed. Report